Cytodyn Inc (CYDY)

[misiu143]

7realone... Yes , these results in our combo study were great..

With 350 mg of leronlimab , efficacy of 81% , and not one serious side effect.

Next 2 drugs approved for these group of patients ,

are..

--Maraviroc with 45% efficacy , and very serious side effects , Black Box warning attached to it..
--Ibalizumab , IV infusion every 2 weeks , and 43% efficacy.

When our combo study finished February 2018 ,

Gilead was doing at this time phase 1 study for their capcid inhibitor , this drug also SC injection given every few months is for the same group of HIV patients as Leronlimab is in combo ..

So FDA worked VERY hard to delay our approval for 3 1/2 years now , until Gilead is ready.

Couple of weeks ago , I read that Gilead just applied for approval for their capcid inhibitor.

Congratulation FDA, Dr Fauci , you did it !!!!!!!!

And with COVID , having good results in over 90 critical patients ,
and in CD12 , group B , critical , over 60 patients ,

with injection at 0 and 7 days , improved mortality benefit above SOC..

is , at ..

--.7 days ,78%
--14 days ,82%
--21 days ,50%
--28 days ,31%

We could see here how beautiful leronlimab is helping these patients to survive , and doctors were right , 2 more doses needed.

And looking at these EIND patients and CD12 group "B" , FDA not giving us EUA in this pandemic , with advise to use 4 doses , is a
CRIMINAL ACT ,
and I hope one day families of people who are dying all the time will go after FDA.
Or someone will , this should not be just left like that.

First FDA sabotage our study , not allowing to have 4 weeks injections . NO , not one even reason for it if doctors asking for 4 weeks ..
Patients using leronlimab for close to 7 years weekly in HIV , without one serious problem ....this was plain , only a sabotage of this study , regardless how many more people will die...

So this is where we are , without all FDA and Fauci being in jail for all this , I don't see any approval for us in USA.

Thank goodness there are other countries , and if our Brazil study will be as good as we think , they will give us EUA and then approval in many other places .

Lets just start this study asap.

GLTA longs ..

And ALL as always IMO.